Woodstock Corp’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $107K | Hold |
29,146
| – | – | 0.01% | 157 |
|
|
2026
Q2 | $124K | Hold |
29,146
| – | – | 0.01% | 159 |
|
|
2026
Q1 | $135K | Hold |
29,146
| – | – | 0.01% | 152 |
|
|
2025
Q4 | $206K | Buy |
29,146
+5,219
| +22% | +$38.5K | 0.02% | 154 |
|
|
2025
Q3 | $185K | Hold |
23,927
| – | – | 0.02% | 156 |
|
|
2025
Q2 | $166K | Sell |
23,927
-1,054
| -4% | -$8.39K | 0.02% | 155 |
|
|
2025
Q1 | $212K | Hold |
24,981
| – | – | 0.02% | 151 |
|
|
2024
Q4 | $350K | Hold |
24,981
| – | – | 0.03% | 135 |
|
|
2024
Q3 | $565K | Hold |
24,981
| – | – | 0.05% | 118 |
|
|
2024
Q2 | $506K | Hold |
24,981
| – | – | 0.05% | 118 |
|
|
2024
Q1 | $622K | Buy |
24,981
+3,502
| +16% | +$74.4K | 0.06% | 111 |
|
|
2023
Q4 | $388K | Buy |
21,479
+926
| +5% | +$15.3K | 0.05% | 127 |
|
|
2023
Q3 | $413K | Hold |
20,553
| – | – | 0.05% | 124 |
|
|
2023
Q2 | $525K | Buy |
20,553
+1,923
| +10% | +$44.7K | 0.06% | 119 |
|
|
2023
Q1 | $396K | Buy |
18,630
+3,790
| +26% | +$95K | 0.05% | 132 |
|
|
2022
Q4 | $439K | Hold |
14,840
| – | – | 0.06% | 126 |
|
|
2022
Q3 | $345K | Buy |
14,840
+4,520
| +44% | +$108K | 0.05% | 129 |
|
|
2022
Q2 | $173K | Hold |
10,320
| – | – | 0.02% | 158 |
|
|
2022
Q1 | $453K | Sell |
10,320
-362
| -3% | -$16.9K | 0.05% | 131 |
|
|
2021
Q4 | $650K | Hold |
10,682
| – | – | 0.07% | 124 |
|
|
2021
Q3 | $444K | Buy |
+10,682
| New | +$374K | 0.05% | 142 |
|
Other funds holding BCYC
Woodstock Corp's BCYC Position: Q3 2026 in Review
Woodstock Corp held its Bicycle Therapeutics (BCYC) position steady in Q3 2026 at 29,146 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #157.
Woodstock Corp first reported a position in BCYC in Q3 2021 and has held it in 21 quarters since. The position peaked at $650K in Q4 2021. 2 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Woodstock Corp held 29,146 shares of Bicycle Therapeutics worth $107K as of Q3 2026.
- Woodstock Corp left its Bicycle Therapeutics share count unchanged in Q3 2026.
- Bicycle Therapeutics made up 0.01% of Woodstock Corp's portfolio in Q3 2026, its #157 holding.
- Woodstock Corp first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 21 quarters since.
- Woodstock Corp's Bicycle Therapeutics position peaked at $650K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Woodstock Corp's 13F filing for Q3 2026, filed 13 Oct 2026.